MARKET NEWS

Calixar Signs Exclusive Licensing Agreement With Regeneron 
Emendo Biotherapeutics Enters Licensing Option Agreement With Takeda
Catalent Invests $40 Million to Increase Patient-Centric Dose Form Manufacturing Capabilities
Braun Medical Uses Needle-Trap from Schreiner MediPharm for New Prefilled Heparin Syringe
International Stem Cell Completes Enrollment & Dosing in its Parkinson's Disease Clinical Trial
Eloxx Pharmaceuticals Presents Positive New Data at ARVO

  FEATURED EDITORIAL

  COMPANY PROFILE

Backed by over 85 years of experience in parenterals, Baxter’s BioPharma Solutions (BPS) business collaborates with pharmaceutical companies to support commercialization objectives for their molecules. BPS is a premier CMO with a focus on injectable pharmaceutical manufacturing designed to meet complex and traditional sterile manufacturing challenges with confidence of delivery, service, and integrity. BPS can support your pharmaceutical needs with a broad portfolio of sterile fill/finish production capabilities, and our reputation is built on the high-quality products we manufacture for our clients in a cGMP environment. Click here for more.

 

 

West is a leading global manufacturer in the design and production of technologically advanced, high quality, integrated containment and delivery systems for injectable medicines. We are a trusted partner to the world’s top pharmaceutical and biotechnology companies – working by their side to improve patient health. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 40 years of experience, we bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging from our eight locations throughout North America and Europe. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Emisphere Provides Development Update on Novo Nordisk Drug Using its Eligen SNAC Carrier Technology

Emisphere Provides Development Update on Novo Nordisk Drug Using its Eligen SNAC Carrier Technology

Novo Nordisk recently announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for oral semaglutide, a glucagon-like peptide-1 (GLP-1) analogue in a tablet taken once-daily, for the treatment of adults with type 2 diabetes.

Oculos & Optceutics Partner to Bring Expanded Services to Ophthalmic Innovators

Oculos & Optceutics Partner to Bring Expanded Services to Ophthalmic Innovators

Oculos and Optceutics recently announced they are entering into a co-promotion arrangement to provide broader services for clients spanning from early research through product approval.

Caris Life Sciences Acquires Pharmatech

Caris Life Sciences Acquires Pharmatech

Caris Life Sciences recently announced it has acquired Pharmatech, Inc., a pioneer of the original Just-In-Time research system with the largest research-ready oncology network.

European Commission Approves Treatment of Moderate-to-Severe Plaque Psoriasis

European Commission Approves Treatment of Moderate-to-Severe Plaque Psoriasis

AbbVie, a research-based global biopharmaceutical company, recently announced that the European Commission (EC) has approved SKYRIZI™ (risankizumab) for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

May 15 – Parenteral Contrqact Manufacturing
May 22 – Nasal Drug Delivery